Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: GBExchange: Nasdaq
DilutionScan read 64 of OKYO Pharma Ltd's SEC filings and found 1 warrant series, 3 convertibles, 2 ATM programs, 1 shelf registration and 1 completed offering on file for OKYO. The latest dilution event on file is an offering on Feb 17, 2026. Analysis updated Oct 18, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
CRBPCorbus Pharmaceuticals Holdings, Inc.
CLLSCellectis S.A. American Depositary Shares
NTRBNutriband Inc.
COYACoya Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
MNOVMediciNova, Inc.
TNYATenaya Therapeutics, Inc.
CINGCingulate Inc.
MAIAMAIA Biotechnology, Inc.
TENXTenax Therapeutics, Inc.
CSBRChampions Oncology, Inc.
TELOTelomir Pharmaceuticals, Inc. Common Stock
NRXSNeurAxis, Inc.
ATRAAtara Biotherapeutics, Inc.
NMADNOMAD Power Solutions, Inc.